Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | HRH2 | P25021 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | HTR4 | Q13639 | 5/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6484741 | 1.00 | KDM4E (0.41) | KDM4EPTGS2KDM1AHRH2HRH1 | |
| SCHEMBL6487284 | 0.99 | KDM4E (0.41) | KDM4EPTGS2KDM1AHRH2HRH1 | |
| SCHEMBL6493983 | 0.78 | HRH2 (0.38) | KDM4EPTGS2KDM1AHRH2HRH1 | |
| SCHEMBL6493552 | 0.77 | DRD3 (0.41) | HRH2HRH1SIGMAR1ALDH1A1 | |
| SCHEMBL6488222 | 0.75 | DRD3 (0.41) | HRH2HRH1SIGMAR1ALDH1A1 | |
| SCHEMBL6487666 | 0.75 | MGLL (0.53) | KDM4EPTGS2KDM1AHRH2HRH1 | |
| SCHEMBL4005408 | 0.72 | ACHE (0.49) | PTGS2ALDH1A1 | |
| SCHEMBL38665905 | 0.70 | GNAI3 (0.53) | KDM4EPTGS2HRH2HRH1SIGMAR1 | |
| SCHEMBL4330983 | 0.70 | ACHE (0.46) | PTGS2ALDH1A1 | |
| SCHEMBL20376410 | 0.68 | HRH2 (0.52) | KDM4EPTGS2KDM1AHRH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861432-B2 | Piperazine derivatives that destabilize androgen receptors | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-03-01 | — | — | US | disclosed |